Tolkachjov SN et al. |
Frontal fibrosing alopecia among men: AÂ clinicopathologic study of 7 cases. |
2017 |
J. Am. Acad. Dermatol. |
pmid:28716436
|
Montenovo MI et al. |
Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. |
2017 |
Exp Clin Transplant |
pmid:27309029
|
Solmaz S et al. |
Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant. |
2017 |
Exp Clin Transplant |
pmid:26643544
|
Das B et al. |
Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients. |
2017 |
Pediatr Transplant |
pmid:27862703
|
Tamashiro EY et al. |
Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. |
2017 |
Drug Metab Pers Ther |
pmid:28593920
|
Charman C |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. |
2017 |
Br. J. Dermatol. |
pmid:28858382
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Chen B et al. |
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder. |
2017 |
Sci Rep |
pmid:28400553
|
Song K et al. |
Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. |
2017 |
Appl. Microbiol. Biotechnol. |
pmid:28349163
|
Wan T et al. |
Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. |
2017 |
Int J Nanomedicine |
pmid:28260894
|
Ferjani H et al. |
Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats. |
2017 |
Exp. Biol. Med. (Maywood) |
pmid:26582055
|
Moes AD et al. |
Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:28259499
|
Tremblay S et al. |
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover Study. |
2017 |
Am. J. Transplant. |
pmid:27340950
|
Qin HZ et al. |
Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients. |
2017 |
BMC Nephrol |
pmid:28056860
|
Terakura S et al. |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil. |
2017 |
Bone Marrow Transplant. |
pmid:27941766
|
Kannegieter NM et al. |
Pharmacodynamic Monitoring of Tacrolimus-Based Immunosuppression in CD14+ Monocytes After Kidney Transplantation. |
2017 |
Ther Drug Monit |
pmid:28640063
|
Wojciechowski D et al. |
Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923623
|
Nanmoku K et al. |
Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923615
|
Gatault P et al. |
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study. |
2017 |
Am. J. Transplant. |
pmid:27862923
|